已收录 268921 条政策
 政策提纲
  • 暂无提纲
Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment
[摘要] Dose–response curves for headaches relief and adverse events (AEs) are presented for five triptans: sumatriptan, zolmitriptan, naratriptan, almotriptan, and frovatriptan, and the CGRP antagonist telcagepant. The upper part of the efficacy curve of the triptans is generally flat, the so-called ceiling effect; and none of the oral triptans, even in high doses, are as effective as subcutaneous sumatriptan, In contrast, AEs increases with increasing dose without a ceiling effect. The optimal dose for the triptans is mainly determined by tolerability. Telcagepant has an excellent tolerability and can be used in migraine patients with cardiovascular co-morbidity. Based on the literature the triptans and telcagepant are rated in a table for efficacy and tolerability.
[发布日期] 2011-02-25 [发布机构] 
[效力级别]  [学科分类] 
[关键词] Migraine;Acute treatment;Triptans;Dose–response curve;Telcagepant [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文